Your session is about to expire
← Back to Search
iTEST for Psychotic Disorders (iTEST Trial)
iTEST Trial Summary
This trial will evaluate a new intervention to help people with psychotic disorders improve their judgement of their abilities & performance, which could improve their functional outcomes.
iTEST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iTEST Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I understand and agree to participate in the study willingly.I am between 18 and 65 years old.I have some difficulty with daily activities but am not working full-time or paying for my household.I need constant medical care that prevents me from attending outpatient therapy.I cannot see or use a smartphone well.I have been diagnosed with schizophrenia or schizoaffective disorder.My medications and health have been stable for the last 2 months.I have been diagnosed with schizophrenia or schizoaffective disorder.I am between 18 and 65 years old.
- Group 1: iTEST
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly individuals aged 85 or greater eligible for participation in this clinical study?
"This clinical trial has set the lower limit for enrollment at 18 years of age and an upper boundary of 65."
Is there the potential to participate in this trial?
"This medical trial is open to individuals between 18 and 65 who are dealing with psychosis. Approximately 60 volunteers will be accepted into the study."
Are there any current open enrollments for this research?
"As per clinicaltrials.gov, this particular medical trial is no longer accepting patients at the moment; it was originally listed on October 1st 2023 and its last update came through in June 2nd of that year. Despite this study's closure, there are still 1548 other trials available for participation as of now."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger